BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36435729)

  • 21. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving clinical prediction rules in acute kidney injury with the use of biomarkers of cell cycle arrest: a pilot study.
    Hodgson LE; Venn RM; Short S; Roderick PJ; Hargreaves D; Selby N; Forni LG
    Biomarkers; 2019 Feb; 24(1):23-28. PubMed ID: 29943653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of acute kidney injury by urinary tissue inhibitor metalloproteinases-2 and insulin-like growth factor-binding protein 7 after pediatric cardiac surgery.
    Tao Y; Heskia F; Zhang M; Qin R; Kang B; Chen L; Wu F; Huang J; Brengel-Pesce K; Chen H; Mo X; Liang J; Wang W; Xu Z
    Pediatr Nephrol; 2022 Nov; 37(11):2743-2753. PubMed ID: 35211796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study.
    Mayer T; Bolliger D; Scholz M; Reuthebuch O; Gregor M; Meier P; Grapow M; Seeberger MD; Fassl J
    J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2072-2079. PubMed ID: 28803769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary Cell-Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury After Ventricular Assist Device Implantation or Cardiac Transplantation.
    Alam A; Jamil AK; Van Zyl JS; Medel-Martinez H; Bottiglieri T; Wasek B; Felius J; Lima B; Hall SA; Joseph SM
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2303-2312. PubMed ID: 34774406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: A prospective multicentre study.
    Titeca-Beauport D; Daubin D; Chelly J; Zerbib Y; Brault C; Diouf M; Slama M; Vinsonneau C; Klouche K; Maizel J
    Resuscitation; 2019 Aug; 141():104-110. PubMed ID: 31216431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass.
    Dong L; Ma Q; Bennett M; Devarajan P
    Pediatr Nephrol; 2017 Dec; 32(12):2351-2360. PubMed ID: 28755073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of the cell cycle arrest biomarkers in the diagnosis of pregnancy-related acute kidney injury.
    El Minshawy O; Khedr MHS; Youssuf AM; Abo Elela M; Kamel FMM; Keryakos HKH
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33295613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of cell cycle arrest biomarkers in patients at high risk for acute kidney injury: A systematic review and meta-analysis.
    Jia HM; Huang LF; Zheng Y; Li WX
    Nephrology (Carlton); 2017 Nov; 22(11):831-837. PubMed ID: 28646585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of urine cell cycle arrest biomarkers to predict persistent acute kidney injury: A systematic review and meta-analysis.
    Jiang W; Yu J; Wang H; Zheng R
    Clin Nephrol; 2021 Dec; 96(6):327-336. PubMed ID: 34605401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Will urinary biomarkers provide a breakthrough in diagnosing cardiac surgery-associated AKI? - A systematic review.
    Hussain ML; Hamid PF; Chakane N
    Biomarkers; 2020 Jul; 25(5):375-383. PubMed ID: 32479185
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery.
    Gist KM; Goldstein SL; Wrona J; Alten JA; Basu RK; Cooper DS; Soranno DE; Duplantis J; Altmann C; Gao Z; Faubel S
    Pediatr Nephrol; 2017 Sep; 32(9):1611-1619. PubMed ID: 28382566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.
    Chindarkar NS; Chawla LS; Straseski JA; Jortani SA; Uettwiller-Geiger D; Orr RR; Kellum JA; Fitzgerald RL
    Clin Chim Acta; 2016 Jan; 452():32-7. PubMed ID: 26522657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.
    Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K
    PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery.
    Wang Y; Zou Z; Jin J; Teng J; Xu J; Shen B; Jiang W; Zhuang Y; Liu L; Luo Z; Wang C; Ding X
    BMC Nephrol; 2017 May; 18(1):177. PubMed ID: 28558754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
    Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
    Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
    Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
    Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck® parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment.
    Knafl D; Müller M; Pajenda S; Genc Z; Hecking M; Wagner L
    PLoS One; 2017; 12(11):e0188316. PubMed ID: 29145491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of kidney function variables with cell cycle arrest biomarkers identifies distinct subphenotypes of sepsis-associated acute kidney injury: a
    Titeca-Beauport D; Diouf M; Daubin D; Vong LV; Belliard G; Bruel C; Zerbib Y; Vinsonneau C; Klouche K; Maizel J
    Ren Fail; 2024 Dec; 46(1):2325640. PubMed ID: 38445412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.